Fresenius Kabi USA LLC:企業の戦略的SWOT分析

◆英語タイトル:Fresenius Kabi USA LLC - Strategic SWOT Analysis Review
◆商品コード:DATA904C15789
◆発行会社(調査会社):GlobalData
◆発行日:2019年4月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fresenius Kabi USA LLC – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Fresenius Kabi USA LLC (Fresenius Kabi), a subsidiary of Fresenius Kabi AG, is a pharmaceutical and medical device company which provides medicines and technologies for infusion, transfusion and clinical nutrition. It provides products and services to critically and chronically ill patients. The company offers injectable drugs and delivery systems, advanced transfusion medicine, cell therapy, infusion, and clinical nutrition technologies. Its products include oncology, anesthesia, analgesia, anti-infectives, parenteral nutrition, iv solutions and other critical care therapies. Fresenius Kabi provides products to hospitals, long-term care facilities, alternate care sites and clinics. It has presence in Canada and operates manufacturing and distributions units in Illinois, New York, Pennsylvania, Puerto Rico, the Dominican Republic, Mississippi and California. Fresenius Kabi is headquartered in Lake Zurich, Illinois, the US.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Fresenius Kabi USA LLC – Key Facts
Fresenius Kabi USA LLC – Key Employees
Fresenius Kabi USA LLC – Key Employee Biographies
Fresenius Kabi USA LLC – Major Products and Services
Fresenius Kabi USA LLC – History
Fresenius Kabi USA LLC – Company Statement
Fresenius Kabi USA LLC – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Fresenius Kabi USA LLC – Business Description
Fresenius Kabi USA LLC – SWOT Analysis
SWOT Analysis – Overview
Fresenius Kabi USA LLC – Strengths
Fresenius Kabi USA LLC – Weaknesses
Fresenius Kabi USA LLC – Opportunities
Fresenius Kabi USA LLC – Threats
Fresenius Kabi USA LLC – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Fresenius Kabi USA LLC, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Fresenius Kabi USA LLC, Key Facts
Fresenius Kabi USA LLC, Key Employees
Fresenius Kabi USA LLC, Key Employee Biographies
Fresenius Kabi USA LLC, Major Products and Services
Fresenius Kabi USA LLC, History
Fresenius Kabi USA LLC, Other Locations
Fresenius Kabi USA LLC, Subsidiaries
Fresenius Kabi USA LLC, Key Competitors
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Fresenius Kabi USA LLC, Recent Deals Summary

List of Figures
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Fresenius Kabi USA LLC, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Fresenius Kabi USA LLC:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mckinsey & Company, Inc.
    Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Mckinsey & Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Singapore Technologies Electronics Ltd:企業の戦略・SWOT・財務情報
    Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Gildan Activewear Inc (GIL):企業の財務・戦略的SWOT分析
    Gildan Activewear Inc (GIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SciGen Ltd (SIE):製薬・医療:M&Aディール及び事業提携情報
    Summary SciGen Ltd (SciGen), a subsidiary of Bioton SA is a biotechnology company that manufactures, develops, and markets recombinant human health care biotechnology derived products. The company’s products include second generation recombinant human insulin, recombinant human growth hormone and si …
  • ACWA Power International:電力:M&Aディール及び事業提携情報
    Summary ACWA Power International (ACWA Power), a subsidiary of ACWA Holding is a power generation company that develops and operates power generation and desalinated water production plants. The company holds a generation portfolio of power and desalinated water. Its projects comprise in selecting i …
  • Shadin Avionics LP:企業の戦略・SWOT・財務分析
    Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report Summary Shadin Avionics LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Aplus Financial Co Ltd.:企業の戦略・SWOT・財務情報
    Aplus Financial Co Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aplus Financial Co Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Regions Financial Corporation:戦略・SWOT・企業財務分析
    Regions Financial Corporation - Strategy, SWOT and Corporate Finance Report Summary Regions Financial Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Isofol Medical AB (ISOFOL):製薬・医療:M&Aディール及び事業提携情報
    Summary Isofol Medical AB (Isofol) is a clinical stage pharmaceutical company that develops folate-based therapies for the treatment of cancer patients. The company offers clinical lead candidate Modufolin, a novel folate-based therapy, which is developed to increase the efficacy and reduce the side …
  • The Depository Trust & Clearing Corporation:企業の戦略的SWOT分析
    The Depository Trust & Clearing Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Volta River Authority:電力:M&Aディール及び事業提携情報
    Summary Volta River Authority (VRA) is a state-owned energy utility that generates, transmits, and distributes electricity. It produces power from solar, hydro, light crude oil, distillate fuel oil, and heavy fuel oil sources. The authority procures energy from Takoradi International Company Ltd; an …
  • China Resources Enterprise Ltd:企業の戦略的SWOT分析
    China Resources Enterprise Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Terna Energy SA (TENERGY):企業の財務・戦略的SWOT分析
    Terna Energy SA (TENERGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Chugoku Electric Power Co Inc (9504):電力:M&Aディール及び事業提携情報
    Summary The Chugoku Electric Power Co Inc (Chugoku Electric) is an integrated energy utility. It generates, transmits and distributes electricity, and supplies offers natural gas and other fuels. The company produces power using thermal, hydro, nuclear, and renewable energy sources. Chugoku Electric …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • BRF SA:企業のM&A・事業提携・投資動向
    BRF SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BRF SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital rais …
  • Four Seasons Hotels and Resorts:企業の戦略的SWOT分析
    Four Seasons Hotels and Resorts - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • BIND Therapeutics Inc (BIND)-製薬・医療分野:企業M&A・提携分析
    Summary BIND Therapeutics Inc (BIND Therapeutics) is a nanomedicine platform company that develops and commercializes preclinical candidates for cardiovascular disease, cancer and inflammatory disease. The company’s pipeline products include BIND-014, an Accurin that contains the well-established ch …
  • Boursorama SA:企業の戦略・SWOT・財務情報
    Boursorama SA - Strategy, SWOT and Corporate Finance Report Summary Boursorama SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Healthscope Ltd:企業の戦略的SWOT分析
    Healthscope Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆